Morning Market Losers By: Benzinga via Benzinga March 23, 2015 at 10:02 AM EDT MEI Pharma, Inc. (NASDAQ: MEIP) shares dipped 68.73% to $1.97 on failed Pracinostat and azacitidine Phase II study. Global-Tech ... Read More >> Related Stocks: Biogen Idec Carnival Corp Gilead Sciences Kansas City Southern Mei Pharma Inc Vertex Pharmaceuticals